Evidence for a role of immunoproteasomes in regulating cardiac muscle mass in diabetic mice

Journal of Molecular and Cellular Cardiology

Volumn 49, Issue 1, 2010, Pages 5-15

  Zu, Lingyun ^a,b   Bedja, Djahida ^c   Fox Talbot, Karen ^a   Gabrielson, Kathleen L ^c   Van Kaer, Luc ^d   Becker, Lewis C ^a   Cai, Zheqing P ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PEKING UNIVERSITY THIRD HOSPITAL   (China)

^c DEPARTMENT OF PATHOLOGY   (United States)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiomyopathy; Heart failure; Hyperglycemia; Proteasome; PTEN

Indexed keywords

EPOXOMICIN; GLUCOSE; IMMUNOPROTEASOME; INSULIN; MYOSIN HEAVY CHAIN; PHOSPHATASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEASOME; PROTEASOME BETA; PROTEIN LMP 2; PROTEIN LMP 7; TENSIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOMYOPATHY; CATALYSIS; CONTROLLED STUDY; DOWN REGULATION; GENE DELETION; HEART FUNCTION; HEART MUSCLE; HEART PERFUSION; HEART WEIGHT; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; ISOLATED HEART; KNOCKOUT GENE; MALE; MOUSE; MUSCLE ATROPHY; MUSCLE MASS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEFECT; PROTEIN DEGRADATION; PROTEIN EXPRESSION; STREPTOZOCIN DIABETES; UPREGULATION;

ANIMALS; CYSTEINE ENDOPEPTIDASES; DIABETES MELLITUS; GLUCOSE; HEART; HYPERGLYCEMIA; INSULIN; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MYOCARDIUM; MYOSIN HEAVY CHAINS; PROTEASOME ENDOPEPTIDASE COMPLEX; PTEN PHOSPHOHYDROLASE; STREPTOZOCIN; UBIQUITIN;

MUS;

EID: 77953360531     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2010.02.007     Document Type: Article

References (38)

1. Ho K.K., Pinsky J.L., Kannel W.B., Levy D. The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol 1993, 22:6A-13A.
2. Kannel W.B., Hjortland M., Castelli W.P. Role of diabetes in congestive heart failure: the Framingham Study. Am J Cardiol 1974, 34:29-34.
3. Jackson C.V., McGrath G.M., Tahiliani A.G., Vadlamudi R.V., McNeill J.H. A functional and ultrastructural analysis of experimental diabetic rat myocardium. Manifestation of a cardiomyopathy. Diabetes 1985, 34:876-883.
4. Aneja A., Tang W.H., Bansilal S., Garcia M.J., Farkouh M.E. Diabetic cardiomyopathy: insights into pathogenesis, diagnostic challenges, and therapeutic options. Am J Med 2008, 121:748-757.
5. Kettelhut I.C., Pepato M.T., Migliorini R.H., Medina R., Goldberg A.L. Regulation of different proteolytic pathways in skeletal muscle in fasting and diabetes mellitus. Braz J Med Biol Res 1994, 27:981-993.
6. Merforth S., Osmers A., Dahlmann B. Alterations of proteasome activities in skeletal muscle tissue of diabetic rats. Mol Biol Rep 1999, 26:83-87.
7. Hu J., Klein J.D., Du J., Wang X.H. Cardiac muscle protein catabolism in diabetes mellitus: activation of the ubiquitin-proteasome system by insulin deficiency. Endocrinology 2008, 149:5384-5390.
8. Willis M.S., Patterson C. Into the heart: the emerging role of the ubiquitin-proteasome system. J Mol Cell Cardiol 2006, 41:567-579.
9. Gillette T.G., Kumar B., Thompson D., Slaughter C.A., DeMartino G.N. Differential roles of the COOH termini of AAA subunits of PA700 (19 S regulator) in asymmetric assembly and activation of the 26 S proteasome. J Biol Chem 2008, 283:31813-31822.
10. Rabl J., Smith D.M., Yu Y., Chang S.C., Goldberg A.L., Cheng Y. Mechanism of gate opening in the 20S proteasome by the proteasomal ATPases. Mol Cell 2008, 30:360-368.
11. Cai Z.P., Shen Z., Van Kaer L., Becker L.C. Ischemic preconditioning-induced cardioprotection is lost in mice with immunoproteasome subunit low molecular mass polypeptide-2 deficiency. FASEB J 2008, 22:4248-4257.
12. Gomes A.V., Young G.W., Wang Y., Zong C., Eghbali M., Drews O., et al. Contrasting proteome biology and functional heterogeneity of the 20S proteasome complexes in mammalian tissues. Mol Cell Proteomics 2009, 8:302-315.
13. Griffin T.A., Nandi D., Cruz M., Fehling H.J., Kaer L.V., Monaco J.J., et al. Immunoproteasome assembly: cooperative incorporation of interferon gamma (IFN-gamma)-inducible subunits. J Exp Med 1998, 187:97-104.
14. Kotamraju S., Matalon S., Matsunaga T., Shang T., Hickman-Davis J.M., Kalyanaraman B. Upregulation of immunoproteasomes by nitric oxide: potential antioxidative mechanism in endothelial cells. Free Radic Biol Med 2006, 40:1034-1044.
15. Schwartzbauer G., Robbins J. The tumor suppressor gene PTEN can regulate cardiac hypertrophy and survival. J Biol Chem 2001, 276:35786-35793.
16. Skurk C., Izumiya Y., Maatz H., Razeghi P., Shiojima I., Sandri M., et al. The FOXO3a transcription factor regulates cardiac myocyte size downstream of AKT signaling. J Biol Chem 2005, 280:20814-20823.
17. Sandri M., Sandri C., Gilbert A., Skurk C., Calabria E., Picard A., et al. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 2004, 117:399-412.
18. Van Kaer L., Ashton-Rickardt P.G., Eichelberger M., Gaczynska M., Nagashima K., Rock K.L., et al. Altered peptidase and viral-specific T cell response in LMP2 mutant mice. Immunity 1994, 1:533-541.
19. Hedhli N., Lizano P., Hong C., Fritzky L.F., Dhar S.K., Liu H., et al. Proteasome inhibition decreases cardiac remodeling after initiation of pressure overload. Am J Physiol Heart Circ Physiol 2008, 295:H1385-H1393.
20. Cai Z., Zhong H., Bosch-Marce M., Fox-Talbot K., Wang L., Wei C., et al. Complete loss of ischaemic preconditioning-induced cardioprotection in mice with partial deficiency of HIF-1 alpha. Cardiovasc Res 2008, 77:463-470.
21. Koitabashi N., Bedja D., Zaiman A.L., Pinto Y.M., Zhang M., Gabrielson K.L., et al. Avoidance of transient cardiomyopathy in cardiomyocyte-targeted tamoxifen-induced MerCreMer gene deletion models. Circ Res 2009, 105:12-15.
22. Martinez C.K., Monaco J.J. Homology of proteasome subunits to a major histocompatibility complex-linked LMP gene. Nature 1991, 353:664-667.
23. Glynne R., Powis S.H., Beck S., Kelly A., Kerr L.A., Trowsdale J. A proteasome-related gene between the two ABC transporter loci in the class II region of the human MHC. Nature 1991, 353:357-360.
24. Barton L.F., Cruz M., Rangwala R., Deepe G.S., Monaco J.J. Regulation of immunoproteasome subunit expression in vivo following pathogenic fungal infection. J Immunol 2002, 169:3046-3052.
25. Chatterjee-Kishore M., Kishore R., Hicklin D.J., Marincola F.M., Ferrone S. Different requirements for signal transducer and activator of transcription 1alpha and interferon regulatory factor 1 in the regulation of low molecular mass polypeptide 2 and transporter associated with antigen processing 1 gene expression. J Biol Chem 1998, 273:16177-16183.
26. Chatterjee-Kishore M., Wright K.L., Ting J.P., Stark G.R. How Stat1 mediates constitutive gene expression: a complex of unphosphorylated Stat1 and IRF1 supports transcription of the LMP2 gene. EMBO J 2000, 19:4111-4122.
27. Khan M.A., Oubrahim H., Stadtman E.R. Inhibition of apoptosis in acute promyelocytic leukemia cells leads to increases in levels of oxidized protein and LMP2 immunoproteasome. Proc Natl Acad Sci USA 2004, 101:11560-11565.
28. Gaczynska M., Rock K.L., Spies T., Goldberg A.L. Peptidase activities of proteasomes are differentially regulated by the major histocompatibility complex-encoded genes for LMP2 and LMP7. Proc Natl Acad Sci USA 1994, 91:9213-9217.
29. Powell S.R., Samuel S.M., Wang P., Divald A., Thirunavukkarasu M., Koneru S., et al. Upregulation of myocardial 11S-activated proteasome in experimental hyperglycemia. J Mol Cell Cardiol 2008, 44:618-621.
30. Harris I.S., Treskov I., Rowley M.W., Heximer S., Kaltenbronn K., Finck B.N., et al. G-protein signaling participates in the development of diabetic cardiomyopathy. Diabetes 2004, 53:3082-3090.
31. Basu R., Oudit G.Y., Wang X., Zhang L., Ussher J.R., Lopaschuk G.D., et al. Type 1 diabetic cardiomyopathy in the Akita (Ins2WT/C96Y) mouse model is characterized by lipotoxicity and diastolic dysfunction with preserved systolic function. Am J Physiol Heart Circ Physiol 2009, 297:H2096-H2108.
32. Fang Z.Y., Prins J.B., Marwick T.H. Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr Rev 2004, 25:543-567.
33. Bugger H., Abel E.D. Rodent models of diabetic cardiomyopathy. Dis Model Mech 2009, 2:454-466.
34. Sijts A.J., Ruppert T., Rehermann B., Schmidt M., Koszinowski U., Kloetzel P.M. Efficient generation of a hepatitis B virus cytotoxic T lymphocyte epitope requires the structural features of immunoproteasomes. J Exp Med 2000, 191:503-514.
35. Crackower M.A., Oudit G.Y., Kozieradzki I., Sarao R., Sun H., Sasaki T., et al. Regulation of myocardial contractility and cell size by distinct PI3K-PTEN signaling pathways. Cell 2002, 110:737-749.
36. Oudit G.Y., Kassiri Z., Zhou J., Liu Q.C., Liu P.P., Backx P.H., et al. Loss of PTEN attenuates the development of pathological hypertrophy and heart failure in response to biomechanical stress. Cardiovasc Res 2008, 78:505-514.
37. Lagirand-Cantaloube J., Cornille K., Csibi A., Batonnet-Pichon S., Leibovitch M.P., Leibovitch S.A. Inhibition of atrogin-1/MAFbx mediated MyoD proteolysis prevents skeletal muscle atrophy in vivo. PLoS One 2009, 4:e4973.
38. Rota M., LeCapitaine N., Hosoda T., Boni A., De Angelis A., Padin-Iruegas M.E., et al. Diabetes promotes cardiac stem cell aging and heart failure, which are prevented by deletion of the p66shc gene. Circ Res 2006, 99:42-52.